Premium
Anti‐epiligrin (laminin 5) cicatricial pemphigoid
Author(s) -
ALLBRITTON J.I.,
NOUSARI H.C.,
ANHALT G.J.
Publication year - 1997
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1046/j.1365-2133.1997.20002081.x
Subject(s) - cicatricial pemphigoid , medicine , pemphigoid , dermatology , cyclophosphamide , autoimmune disease , laminin , antibody , bullous pemphigoid , immunology , chemotherapy , surgery , genetics , biology , cell
Summary Cicatricial pemphigoid is an autoimmune disease predominantly of elderly patients. Recently, a subtype of cicatricial pemphigoid with antibodies to epiligrin (laminin 5) was described. We report a patient in whom anti‐epiligrin cicatricial pemphigoid was identified. He presented with cutaneous, oral and ocular involvement. He has shown initial improvement on corticosteroids and cyclophosphamide.